December 21, 2022
1 min read

Indian firm culpable for cough syrup deaths, says Gambia panel

The panel added that the exact scientific cause of the children’s deaths was still under investigation…reports Asian Lite News

A parliamentary committee in The Gambia has recommended prosecution of an Indian manufacturer of cough syrups suspected of causing the deaths of at least 70 children in the West African country.

After weeks of investigation, the Gambian parliamentary committee has now recommended that authorities should take tough measures, including banning all Maiden Pharmaceuticals products in the country and taking legal action against the firm, reports the BBC.

“The findings remain the same with the previous reports which indicates that Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup were contaminated with diethylene glycol and ethylene glycol,” the parliamentary committee said in its report.

Diethylene glycol and ethylene glycol are toxic to humans and could be fatal if consumed. But the panel added that the exact scientific cause of the children’s deaths was still under investigation.

The committee also wanted the country’s Medicine Control Agency to ensure all medicines imported into the country are properly registered and background checks conducted on manufacturers, including visiting their facilities, reports the BBC.

The report also revealed inadequacies in the country’s healthcare system urging the government to strengthen it and provide better equipment and medicines to hospitals.

In late July, The Gambia detected an increase in cases of acute kidney injury among children under the age of five.

The government later said around 69 children had died from these injuries.

The WHO then identified four of the Maiden Pharmaceuticals’ medicines as potentially linked to the deaths of the Gambian children and issued a global alert.

But Maiden Pharmaceuticals had denied the allegations, the BBC reported.

Government labs in India said their tests on the syrups found that they were “complying with specifications”.

An Indian official said last week that the WHO was “presumptuous” in blaming the syrups.

But the global health body told the BBC it was only following its mandate and “stands by the action taken”.

ALSO READ: India offers migrant training to be model residents in Gulf

Previous Story

‘Film making is voice, but it’s also craft and versatility’

Next Story

Venus Williams receives wild card for ASB Classic

Latest from -Top News

Trump tariffs send world markets into panic

US benchmark crude oil shed $2.70 to $64.25 a barrel after major oil producers announced they plan to increase production. Brent crude, the international standard, was down $2.63 at $67.51 a barrel

EU prepares retaliation for Trump’s tariffs

The European Commission is assembling a fresh round of counter-tariffs aimed at US goods, adding to two existing lists of potential targets—one of which includes products that were hit by suspended tariffs

US, EU slam China’s war games near Taiwan

US President Donald Trump underscored the need to maintain peace in the Taiwan Strait, advocating for a diplomatic approach to cross-strait tensions while warning against the use of force The United States

£13.9 billion of R&D fund to boost innovation, jobs

Funding outlined to support transformational R&D in areas like life sciences, green energy, engineering and beyond More UK innovators like those developing treatment-transforming dementia tests or building world-leading testing facilities to power
Go toTop

Don't Miss

The Gambia celebrates its National Day at Expo 2020

Expo 2020 Dubai today celebrated the National Day of Gambia,

India-Gambia ready to refurbish governance reforms

The step will be taken as the Union Cabinet on